Watch: the CureRays® explainer series
Prefer to read? The full guide below is complete on its own, with tables you can revisit any time.
What is apocrine carcinoma of the skin?
The skin has two kinds of sweat glands; the apocrine glands are concentrated in the armpit, groin, and around the nipple and genitals. Primary cutaneous apocrine carcinoma is a very rare cancer that grows from these glands, usually appearing as a slow-growing lump or nodule in those areas in middle-aged and older adults. Although it often grows slowly, it has a meaningful tendency to reach nearby lymph nodes and can recur, so it is taken seriously. Because some apocrine carcinomas carry hormone receptors (similar to certain breast cancers), hormone-blocking therapy is occasionally an option for advanced disease. As with other sweat-gland cancers, doctors first confirm the skin is the true origin rather than spread from the breast.
The main types
Doctors group apocrine carcinoma of the skin by where it starts and how it behaves:
| Type | What it means, simply |
|---|---|
| Classic apocrine carcinoma | Arises in apocrine-gland-rich skin (underarm, groin, genital area); slow-growing but can reach lymph nodes. |
| Hormone-receptor-positive | Some tumors carry estrogen/androgen receptors, opening the door to anti-hormone pills for advanced cases. |
| Apocrine hidradenocarcinoma overlap | Closely related sweat-gland cancers can share features; expert pathology sorts out the exact subtype. |
Staging, in plain terms
Care is guided by tumor size and depth, whether lymph nodes are involved, and completeness of removal. Because the tumor can travel to nodes more than other sweat-gland cancers, node status is a key part of the picture.
| Skin-adnexal TNM (size/depth + nodes), individualized | What it generally means |
|---|---|
| Localized | Confined to the skin with no node involvement; good outlook with complete removal. |
| Node-positive | Has reached nearby lymph nodes — relatively common for this tumor — and is then treated more aggressively. |
| Locally recurrent | Returned after prior surgery; needs wider treatment, often with radiation. |
| Metastatic | Distant spread; managed with systemic therapy, including anti-hormone pills when the tumor is receptor-positive. |
The standard of care
Apocrine Carcinoma of the Skin is almost always treated by a team that may include a surgeon, a medical oncologist, and a radiation oncologist, combining therapies for the best result. The usual building blocks are:
Wide surgical excision
Removing the tumor with clear margins is the main treatment; Mohs micrographic surgery is used in cosmetically or functionally sensitive areas.
Lymph node evaluation
Because nodal spread is relatively common, the draining nodes are checked (sometimes with a sentinel-node biopsy) and removed if involved.
Radiation and systemic therapy
Radiation for high-risk or node-positive disease; chemotherapy or hormone-blocking pills (for receptor-positive tumors) for advanced or metastatic cases.
How radiation treatment works
Radiation focuses high-energy beams on the tumor area to break the DNA of cancer cells so they can no longer divide, clearing microscopic disease that surgery may leave behind. For apocrine carcinoma, radiation is mainly used after surgery for high-risk or node-positive tumors, or to treat involved lymph nodes, improving local and regional control. The beam is shaped to the surgical bed and any at-risk nodes while sparing surrounding skin and tissue. Treatment is painless and delivered as a series of short daily sessions, with a temporary skin reaction being the usual side effect.
The main ways radiation is delivered for apocrine carcinoma of the skin:
Adjuvant external-beam radiation
Targets the tumor bed and, when needed, the draining nodes after surgery to lower the chance of local and regional recurrence in high-risk tumors.
Nodal radiation
When lymph nodes are involved or there is concern for residual disease, the nodal area is irradiated as part of regional control.
Anti-hormone therapy (selective)
For hormone-receptor-positive tumors that have spread, androgen- or estrogen-blocking pills can slow the cancer — a strategy borrowed from breast-cancer care.
Latest studies shaping care
Care keeps improving — often toward getting the same excellent results with less burden on patients. A few developments:
Radiotherapy for cutaneous adnexal carcinoma: A 20-year, 49-patient experience supports surgery-plus-radiation for sweat-gland skin cancers including apocrine carcinoma, with good local control in higher-risk tumors.[1]
PMC12421330 (2025)
Anti-androgen therapy in metastatic apocrine carcinoma: Case evidence shows metastatic cutaneous apocrine adenocarcinoma responding to systemic anti-androgen therapy, supporting receptor testing of advanced tumors.[2]
Clinical Case Reports (Wiley, 2020)
Apocrine/eccrine adnexal management review: Review of sweat-gland skin cancers outlines diagnosis and the role of surgery, lymph-node assessment, and radiation for apocrine-differentiated tumors.[3]
Int. J. Molecular Sciences (MDPI 22:5077)
Common questions
Where does this cancer usually appear? In areas rich in apocrine sweat glands — most often the armpit and groin, and sometimes around the nipple or genitals — as a slow-growing lump.
Why are my lymph nodes being checked? Apocrine carcinoma reaches the nearby lymph nodes more often than most sweat-gland cancers, so checking and, if needed, treating them is an important part of care.
I heard it can be treated like breast cancer — is that true? Sometimes. A portion of apocrine carcinomas carry hormone receptors, so for advanced disease, hormone-blocking pills used in breast cancer can be an option after the tumor is tested.
References
Numbered sources for the studies cited above. Links open the primary publication on PubMed or the publisher’s site.